2024 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
14.3 M |
13.2 % |
2023 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
12.6 M |
133.4 % |
2022 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
5.4 M |
33.3 % |
2021 |
Viking Therapeutics Inc
|
- |
4.1 M |
-21.8 % |
2021 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
4.1 M |
-21.8 % |
2020 |
Viking Therapeutics Inc
|
- |
5.2 M |
47.7 % |
2020 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
5.2 M |
47.7 % |
2020 |
Viking Therapeutics Inc
|
- |
5.2 M |
47.7 % |
2019 |
Viking Therapeutics Inc
|
- |
3.5 M |
150.3 % |
2019 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
3.5 M |
150.3 % |
2019 |
Viking Therapeutics Inc
|
- |
3.5 M |
150.3 % |
2018 |
Viking Therapeutics Inc
|
- |
1.4 M |
74.4 % |
2018 |
Viking Therapeutics Inc
|
- |
1.4 M |
74.4 % |
2018 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
1.4 M |
74.4 % |
2017 |
Viking Therapeutics Inc
|
- |
804.7 K |
6.3 % |
2017 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
804.7 K |
6.3 % |
2017 |
Viking Therapeutics Inc
|
- |
804.7 K |
6.3 % |
2016 |
Viking Therapeutics Inc
|
- |
756.9 K |
-65.4 % |
2016 |
Viking Therapeutics Inc
|
- |
756.9 K |
-65.4 % |
2016 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
756.9 K |
-65.4 % |
2015 |
Viking Therapeutics Inc
|
- |
2.2 M |
478.8 % |
2015 |
Viking Therapeutics Inc
|
- |
2.2 M |
478.8 % |
2015 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Director |
2.2 M |
478.8 % |
2014 |
Viking Therapeutics Inc
|
- |
377.6 K |
855.9 % |
2014 |
Viking Therapeutics Inc
|
- |
377.6 K |
855.9 % |
2013 |
Viking Therapeutics Inc
|
President, Chief Executive Officer and Interim Chairman of the Board |
39.5 K |
- |